Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CS 101

Next Previous
Drug Profile

CS 101

Alternative Names: CS-101

Latest Information Update: 13 Dec 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CorrectSequence Therapeutics
  • Developer CorrectSequence Therapeutics; The First Affiliated Hospital Of Guangxi Medical University
  • Class Gene therapies; Haematopoietic stem cells therapies
  • Mechanism of Action Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Beta-thalassaemia
  • Phase 0 Sickle cell anaemia

Most Recent Events

  • 05 Dec 2024 CorrectSequence Therapeutics initiates enrolment in an observational trial for Beta-Thalassemia in China (NCT06717932)
  • 12 Nov 2024 CorrectSequence Therapeutics initiates enrolment in a long-term clinical trial for Beta-thalassaemia (In adolescents, In adults, In children) in China (Parenteral), (NCT06685536)
  • 21 Aug 2024 Phase-0 for Sickle cell anaemia (In children, In adolescents, In adults) in China (Parenteral) (NCT06565026)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top